Evidence map›Paper›PMID 36647790›Full record

ArticleCancer biology & medicine2023

Acetylated-PPARγ expression is regulated by different

Kexin Zhang, Xiaohui Yang, Minying Zheng, Yidi Ning, Shiwu Zhang

Open access · goldAbstract read
In one paragraph

Article in Cancer biology & medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kexin Zhang *Tianjin Union Medical Center, Tianjin 300122, China.
Xiaohui Yang *Nankai University School of Medicine, Nankai University, Tianjin 300071, China.
Minying ZhengTianjin Union Medical Center, Tianjin 300122, China.
Yidi NingNankai University School of Medicine, Nankai University, Tianjin 300071, China.
Shiwu ZhangTianjin Union Medical Center, Tianjin 300122, China.ORCID 0000-0002-5052-2283
Tianjin People's Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePolyploid giant cancer cells (PGCCs) with daughter cells express epithelial-mesenchymal transition (EMT)-associated proteins. Highly malignant tumor cells with EMT properties can transdifferentiate into mature tumor cells. In this study, we elucidated the potential for, and underlying mechanism of, adipogenic differentiation of PGCCs with daughter cells (PDCs).

methodsCobalt chloride was used to induce PGCC formation in HEY (wild-type

resultsPDCs transdifferentiated into functional adipocytes. Two different cell cycle distributions were observed in PDCs after adipogenic differentiation. The expression levels of PPARγ, Ace-PPARγ, and Ace-P53 were higher in PDCs after adipogenic differentiation than in cells before adipogenic differentiation. Ace-PPARγ and FABP4 expression increased in HEY cells and decreased in MDA-MB-231 PDCs after

conclusionsAcetylation of P53 and PPARγ plays an important role in the adipogenic differentiation of PDCs.

Indexed as

NeoplasmsPPAR gammaAdipogenesisAnimalsCell DifferentiationHumansPolyploidyTumor Suppressor Protein p53PPAR gammaTumor Suppressor Protein p53adipogenic differentiationPGCCspost-translational modificationPPARγ

Identifiers

PMID36647790
PMCPMC9843444
OpenAlexW4315865515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.